adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agentes antineoplásicos - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.
humalog mix 25 100 u/ml. suspensión inyectable
eli lilly and company [us] united states - insulina lispro 100 u/ml (3,5mg) (insulina lispro 25 u insulina lispro protamina 75 u) - suspension inyectable - cada ml contiene: insulina lispro (1) 100 u (3,5mg) origen adn recombinante cas 133107-64-9
humalog 100 u/ml solución inyectable en cartuchos
eli lilly and company [us] united states - insulina lispro 100u (3.5 mg) - soluciÓn inyectable - cada ml contiene insulina lispro 100u (3.5 mg) (origen adn recombinante) (cas 133107-64-9)
nistaglos® nf ungüento
grunenthal ecuatoriana cia ltda ecuador - a) nistatina 2,2727g + 25% exceso (equivalente a 10.000.000 ui) Óxido de zinc 20.0000g - ungÜento - cada 100g de ungüento contiene: a) nistatina 2,2727g + 25% exceso (equivalente a 10.000.000 ui) Óxido de zinc 20.0000g
cyramza® 10mg/ml
eli lilly and company estados unidos - ramucirumab 10mg/ml - solucion inyectable para perfusion intravenosa - cada ml contiene: ramucirumab 10mg
adcetris 50 mg 1 vial pols
saflutan 15 microgramos/ml colirio en solucion en envase unidosis
santen oy - tafluprost - excipientes: glicerol,dihidrogenofosfato de sodio dihidratado,edetato de disodio,polisorbato 80,hidroxido de sodio (e-524) - preparados contra el glaucoma y miÓticos1) - análogos de prostaglandinas - tafluprost
yasmin 3 mg/0,03 mg comprimidos recubiertos con pelicula
bayer hellas abee - drospirenona, etinilestradiol - excipientes: almidon de maiz,lactosa monohidrato,almidon de maiz pregelatinizado - anticonceptivos hormonales para uso sistÉmico - progestágenos y estrógenos, preparados de dosis fijas - drospirenona y estrógeno
vasocad 20 ui/ml solucion inyectable
drogueria cadillo s.a.c - droguerÍa - vasopresina; - solucion inyectable - por parche - - vasopresina
herceptin
f. hoffman-la roche ltd, suiza. - trastuzumab -